Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
vß3 integrin expression up-regulates cdc2, which modulates cell migration
Thomas Manes1,
Duo-Qi Zheng1,
Simona Tognin2,
Amy S. Woodard1,
Pier Carlo Marchisio2, and
Lucia R. Languino1,3
1 Department of Pathology, Yale University School of Medicine, New Haven, CT 06510 2 DIBIT-Department of Biological and Technological Research, University Vita-Salute San Raffaele School of Medicine, 20132 Milan, Italy 3 Department of Cancer Biology and Cancer Center, University of Massachusetts Medical School, Worcester, MA 01605
Address correspondence to L.R. Languino, Dept. of Cancer Biology, University of Massachusetts Medical School, LRB, 364 Plantation St., Room 417, Worcester, MA 01605. Tel.: (508) 856-1606. Fax: (508) 856-3845. E-mail: Lucia.Languino{at}umassmed.edu
Abstract:
The vß3 integrin has been shown to promote cell migrationthrough activation of intracellular signaling pathways. We describehere a novel pathway that modulates cell migration and thatis activated by vß3 and, as downstream effector, bycdc2 (cdk1). We report that vß3 expression in LNCaP(ß3-LNCaP) prostate cancer cells causes increasedcdc2 mRNA levels as evaluated by gene expression analysis, andincreased cdc2 protein and kinase activity levels. We providethree lines of evidence that increased levels of cdc2 contributeto a motile phenotype on integrin ligands in different celltypes. First, increased levels of cdc2 correlate with more motilephenotypes of cancer cells. Second, ectopic expression of cdc2increases cell migration, whereas expression of dominant-negativecdc2 inhibits migration. Third, cdc2 inhibitors reduce cellmigration without affecting cell adhesion. We also show thatcdc2 increases cell migration via specific association withcyclin B2, and we unravel a novel pathway of cell motility thatinvolves, downstream of cdc2, caldesmon. cdc2 and caldesmonare shown here to localize in membrane ruffles in motile cells.These results show that cdc2 is a downstream effector of thevß3 integrin, and that it promotes cell migration.
Amy S. Woodard's present name and address is Amy S. WoodardFreyman, Genetics Institute/Wyeth-Ayerst Research, 87 CambridgePark Dr., Cambridge, MA 02140.
* Abbreviations used in this paper: 2D, two dimensional; 3D, threedimensional; FN, fibronectin; IB, immunoblotting; MEF, mouseembryonic fibroblast; VN, vitronectin; wt, wild type.
The editors suggest the following Related Resources on Science sites:
Quantitative Imaging of Epithelial Cell Scattering Identifies Specific Inhibitors of Cell Motility and Cell-Cell Dissociation.
D. Loerke, Q. le Duc, I. Blonk, A. Kerstens, E. Spanjaard, M. Machacek, G. Danuser, and J. de Rooij (2012)
Science Signaling
5, rs5
|Abstract »|Full Text »|PDF »
p27kip1 Controls Cell Morphology and Motility by Regulating Microtubule-Dependent Lipid Raft Recycling.
B. Belletti, I. Pellizzari, S. Berton, L. Fabris, K. Wolf, F. Lovat, M. Schiappacassi, S. D'Andrea, M. S. Nicoloso, S. Lovisa, et al. (2010)
Mol. Cell. Biol.
30, 2229-2240
|Abstract »|Full Text »|PDF »
A Single Nucleotide Change in the Mouse Genome Accelerates Breast Cancer Progression.
N. Seitzer, T. Mayr, S. Streit, and A. Ullrich (2010)
Cancer Res.
70, 802-812
|Abstract »|Full Text »|PDF »
{beta}1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1.
H. L. Goel, L. Moro, J. E. Murphy-Ullrich, C.-C. Hsieh, C.-L. Wu, Z. Jiang, and L. R. Languino (2009)
Cancer Res.
69, 5374-5382
|Abstract »|Full Text »|PDF »
Cyclin-Dependent Kinase Inhibitors Block Leukocyte Adhesion and Migration.
L. Liu, B. Schwartz, Y. Tsubota, E. Raines, H. Kiyokawa, K. Yonekawa, J. M. Harlan, and L. M. Schnapp (2008)
J. Immunol.
180, 1808-1817
|Abstract »|Full Text »|PDF »
Cdc2-mediated Schwann cell migration during peripheral nerve regeneration.
I. S. Han, T. B. Seo, K.-H. Kim, J.-H. Yoon, S.-J. Yoon, and U. Namgung (2007)
J. Cell Sci.
120, 246-255
|Abstract »|Full Text »|PDF »
Aberrant Splicing of Cyclin-Dependent Kinase-Associated Protein Phosphatase KAP Increases Proliferation and Migration in Glioblastoma.
Y. Yu, X. Jiang, B. S. Schoch, R. S. Carroll, P. M. Black, and M. D. Johnson (2007)
Cancer Res.
67, 130-138
|Abstract »|Full Text »|PDF »
Cyclin D1 Induction of Cellular Migration Requires p27KIP1..
Z. Li, X. Jiao, C. Wang, X. Ju, Y. Lu, L. Yuan, M. P. Lisanti, S. Katiyar, and R. G. Pestell (2006)
Cancer Res.
66, 9986-9994
|Abstract »|Full Text »|PDF »
Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling.
Z. Li, C. Wang, X. Jiao, Y. Lu, M. Fu, A. A. Quong, C. Dye, J. Yang, M. Dai, X. Ju, et al. (2006)
Mol. Cell. Biol.
26, 4240-4256
|Abstract »|Full Text »|PDF »
A Discoidin Domain Receptor 1/SHP-2 Signaling Complex Inhibits {alpha}2beta1-Integrin-mediated Signal Transducers and Activators of Transcription 1/3 Activation and Cell Migration.
C.-Z. Wang, H.-W. Su, Y.-C. Hsu, M.-R. Shen, and M.-J. Tang (2006)
Mol. Biol. Cell
17, 2839-2852
|Abstract »|Full Text »|PDF »
Deregulation of HEF1 Impairs M-Phase Progression by Disrupting the RhoA Activation Cycle.
D. Dadke, M. Jarnik, E. N. Pugacheva, M. K. Singh, and E. A. Golemis (2006)
Mol. Biol. Cell
17, 1204-1217
|Abstract »|Full Text »|PDF »
{beta}1 Integrins Modulate Cell Adhesion by Regulating Insulin-Like Growth Factor-II Levels in the Microenvironment.
H. L. Goel, L. Moro, M. King, N. Teider, M. Centrella, T. L. McCarthy, M. Holgado-Madruga, A. J. Wong, E. Marra, and L. R. Languino (2006)
Cancer Res.
66, 331-342
|Abstract »|Full Text »|PDF »
HCaRG increases renal cell migration by a TGF-{alpha} autocrine loop mechanism.
C. E. Hader, S. Tremblay, N. Solban, D. Gingras, R. Beliveau, S. N. Orlov, P. Hamet, and J. Tremblay (2005)
Am J Physiol Renal Physiol
289, F1273-F1280
|Abstract »|Full Text »|PDF »
Cyclin E Overexpression Obstructs Infiltrative Behavior in Breast Cancer: A Novel Role Reflected in the Growth Pattern of Medullary Breast Cancers.
P. Berglund, M. Stighall, K. Jirstrom, S. Borgquist, A. Sjolander, I. Hedenfalk, and G. Landberg (2005)
Cancer Res.
65, 9727-9734
|Abstract »|Full Text »|PDF »
Regulation of Microfilament Organization by Kaposi Sarcoma-associated Herpes Virus-cyclin{middle dot}CDK6 Phosphorylation of Caldesmon.
M. E. Cuomo, A. Knebel, G. Platt, N. Morrice, P. Cohen, and S. Mittnacht (2005)
J. Biol. Chem.
280, 35844-35858
|Abstract »|Full Text »|PDF »
{beta}1A Integrin Expression Is Required for Type 1 Insulin-Like Growth Factor Receptor Mitogenic and Transforming Activities and Localization to Focal Contacts.
H. L. Goel, M. Breen, J. Zhang, I. Das, S. Aznavoorian-Cheshire, N. M. Greenberg, A. Elgavish, and L. R. Languino (2005)
Cancer Res.
65, 6692-6700
|Abstract »|Full Text »|PDF »
Down-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation.
L. Moro, A. A. Arbini, E. Marra, and M. Greco (2005)
J. Biol. Chem.
280, 22482-22491
|Abstract »|Full Text »|PDF »
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.
S. Achilefu, S. Bloch, M. A. Markiewicz, T. Zhong, Y. Ye, R. B. Dorshow, B. Chance, and K. Liang (2005)
PNAS
102, 7976-7981
|Abstract »|Full Text »|PDF »
Phosphorylation of actopaxin regulates cell spreading and migration.
D. M. Clarke, M. C. Brown, D. P. LaLonde, and C. E. Turner (2004)
J. Cell Biol.
166, 901-912
|Abstract »|Full Text »|PDF »
Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by {beta}1 integrins.
H. L. Goel, M. Fornaro, L. Moro, N. Teider, J. S. Rhim, M. King, and L. R. Languino (2004)
J. Cell Biol.
166, 407-418
|Abstract »|Full Text »|PDF »
Cytoplasmic p21Cip1 Is Involved in Ras-induced Inhibition of the ROCK/LIMK/Cofilin Pathway.